9. Systemic therapy naïve in the metastatic setting. Prior systemic therapy is permitted but minimum time interval (as per primary site) from last dose of cytotoxic chemotherapy to first fraction of SBRT is allowed as per primary site listed in criterion 4 above. Concurrent endocrine therapy with SBRT is allowed.